Значения термина Plasmodium vivax на английском

The prevalence of Plasmodium vivax infection has been increasing in the past decades.

We have recently described a Plasmodium vivax-like human malaria parasite.

People lacking the receptor are protected against infection by a malaria parasite known as Plasmodium vivax.

Most pregnant women at risk of for infection with Plasmodium vivax live in the Asia-Pacific region.

The protozoan Plasmodium vivax is responsible for 42% of all cases of malaria outside Africa.

The widespread distribution and relapsing nature of Plasmodium vivax infection present major challenges for the elimination of malaria.

These data are key to a rational drug policy for malaria elimination of Plasmodium falciparum and Plasmodium vivax.

The gene encoding a cysteine proteinase of the human malaria parasite Plasmodium vivax has been identified and characterized.

This study aimed to provide data on the therapeutic efficacy of CQ against Plasmodium vivax malaria in southern Ethiopia.

Differential diagnosis is particularly important in cases of Plasmodium vivax, a species that shares endemicity with P. falciparum in most endemic areas.

Background: How antimalarial antibodies are acquired and maintained during pregnancy and boosted after reinfection with Plasmodium falciparum and Plasmodium vivax is unknown.

Little is known of the genetic diversity and population structure of Plasmodium vivax, a debilitating and highly prevalent malaria parasite of humans.

No radical treatment with primaquine was provided for Plasmodium vivax cases, which could explain the slow decrease of P. vivax due to relapses.

To determine the magnitude of Plasmodium vivax relapsing malaria in rural Amazonia, we carried out a study in four sites in northeastern Peru.

Background: Plasmodium vivax is the second most prevalent malaria parasite affecting more than 75 million people each year, mostly in South America and Asia.

This study tested the hypothesis that pro- or anti-inflammatory cytokines are associated with transmission of Plasmodium vivax to Anopheles darlingi mosquitoes in experimental infection.